Member LoginDividend CushionValue Trap
|
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Latest
Valuentum Commentary
Jun 22, 2014
Valuentum Economic Castle™ Rating Update
Members should expect the initial Economic Castle™ ratings. Mar 7, 2014
Dividend Increases/Decreases for the Week Ending March 7
Let's take a look at dividend increases/decreases for the week ending March 7. Jan 27, 2014
Surveying Fourth Quarter Earnings at Health Care Firms
Though it may be difficult to focus on underlying equity fundamentals in the face of a volatile overall market environment, we think doing so is even more important under such circumstances. Let’s examine our thoughts on fourth-quarter earnings season in the health care space . Sep 26, 2013
MAKO Receives a Tremendous Offer from Stryker; Is Intuitive Surgical Next?
MAKO receives an offer from Stryker that was an 83% premium to its previous day's closing price. Let’s take a look at the deal and what it may mean for Intuitive Surgical. Mar 8, 2013
Firms Raising Their Dividends in the Week Ending March 8
This week, a plethora of firms raised their dividends. Aug 23, 2012
Search Dividend Reports by Company Name: Q to Z
Search dividend reports by company name: Q to Z. As a supplement to our 16-page stock reports, our dividend reports assess the safety of a firm's dividend through our Valuentum Dividend Cushion ratio, the potential growth of a firm's dividend by evaluating its capacity and willingness to increase the dividend, the historical track record of the company's dividend performance, and the overall strength of the dividend by putting all of this analysis together. Each report offers our estimate of the future growth rate of the firm's dividend. Jun 13, 2012
Johnson and Johnson’s Deal for Synthes Closes; Healthcare Spending Will Grow
We take a look at some recent developments in the healthcare industry. Latest News and Media The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
